Remote ischaemic pre-conditioning, kidney injury, and outcomes after coronary angiography and intervention: a randomized trial

IF 35.6 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS European Heart Journal Pub Date : 2025-03-11 DOI:10.1093/eurheartj/ehaf135
Ping Jia, Gang Zhao, Yuli Huang, Zhouping Zou, Qi Zeng, Weize Chen, Ting Ren, Yang Li, Xiaoyan Wang, Tingting Kang, Zhihe Liu, Mengqing Ma, Jiwei Yu, Qiong Wu, Bing Deng, Xiaoxiang Yan, Xin Wan, Xin Chen, Changchun Cao, Junbo Ge, Xiaoqiang Ding
{"title":"Remote ischaemic pre-conditioning, kidney injury, and outcomes after coronary angiography and intervention: a randomized trial","authors":"Ping Jia, Gang Zhao, Yuli Huang, Zhouping Zou, Qi Zeng, Weize Chen, Ting Ren, Yang Li, Xiaoyan Wang, Tingting Kang, Zhihe Liu, Mengqing Ma, Jiwei Yu, Qiong Wu, Bing Deng, Xiaoxiang Yan, Xin Wan, Xin Chen, Changchun Cao, Junbo Ge, Xiaoqiang Ding","doi":"10.1093/eurheartj/ehaf135","DOIUrl":null,"url":null,"abstract":"Background and Aims Remote ischaemic pre-conditioning (RIPC) delivered shortly prior to an angiographic procedure may reduce contrast-associated acute kidney injury (CA-AKI). Whether a longer interval between RIPC and contrast administration also reduces CA-AKI and post-procedural complications after coronary angiography (CAG) or percutaneous coronary intervention (PCI) is unknown. Methods This was a multicentre, randomized trial of patients at risk of CA-AKI undergoing elective CAG or PCI comparing delayed RIPC (four cycles of 5 min inflations on one upper arm 24 h before the procedure) with sham RIPC. The primary endpoint was the incidence of AKI, defined according to the Kidney Disease Improving Global Outcomes criteria. Secondary endpoints included renal replacement therapy during hospitalization, changes in urinary biomarkers of kidney injury, and occurrence of non-fatal myocardial infarction, stroke, re-hospitalization, and all-cause mortality by day 90. Results Altogether, 501 patients (age, 74 [66, 78] years) were randomly assigned to delayed (n = 250) or sham (n = 251) RIPC, of which 467 (93.2%) completed outcome assessments at day 90. The incidence of CA-AKI was 7.6% with sham and 3.2% with delayed RIPC (odds ratio 0.4, 95% confidence interval 0.17–0.94; P = .03). The trial was not adequately powered to show effects on secondary outcomes. Conclusions Among at-risk patients undergoing CAG or PCI, the incidence of CA-AKI was lower in patients receiving delayed compared with sham RIPC. These results should be confirmed in larger trials to investigate whether reductions in CA-AKI with delayed RIPC lead to important clinical benefits.","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":"54 1","pages":""},"PeriodicalIF":35.6000,"publicationDate":"2025-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Heart Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/eurheartj/ehaf135","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background and Aims Remote ischaemic pre-conditioning (RIPC) delivered shortly prior to an angiographic procedure may reduce contrast-associated acute kidney injury (CA-AKI). Whether a longer interval between RIPC and contrast administration also reduces CA-AKI and post-procedural complications after coronary angiography (CAG) or percutaneous coronary intervention (PCI) is unknown. Methods This was a multicentre, randomized trial of patients at risk of CA-AKI undergoing elective CAG or PCI comparing delayed RIPC (four cycles of 5 min inflations on one upper arm 24 h before the procedure) with sham RIPC. The primary endpoint was the incidence of AKI, defined according to the Kidney Disease Improving Global Outcomes criteria. Secondary endpoints included renal replacement therapy during hospitalization, changes in urinary biomarkers of kidney injury, and occurrence of non-fatal myocardial infarction, stroke, re-hospitalization, and all-cause mortality by day 90. Results Altogether, 501 patients (age, 74 [66, 78] years) were randomly assigned to delayed (n = 250) or sham (n = 251) RIPC, of which 467 (93.2%) completed outcome assessments at day 90. The incidence of CA-AKI was 7.6% with sham and 3.2% with delayed RIPC (odds ratio 0.4, 95% confidence interval 0.17–0.94; P = .03). The trial was not adequately powered to show effects on secondary outcomes. Conclusions Among at-risk patients undergoing CAG or PCI, the incidence of CA-AKI was lower in patients receiving delayed compared with sham RIPC. These results should be confirmed in larger trials to investigate whether reductions in CA-AKI with delayed RIPC lead to important clinical benefits.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
冠状动脉造影和介入治疗后的远程缺血预处理、肾损伤和预后:随机试验
背景和目的在血管造影前进行远程缺血预处理(RIPC)可以减少对比剂相关的急性肾损伤(CA-AKI)。RIPC和造影剂之间较长的间隔是否也能减少CA-AKI和冠状动脉造影(CAG)或经皮冠状动脉介入治疗(PCI)后的术后并发症尚不清楚。方法:这是一项多中心随机试验,对有CA-AKI风险的患者进行选择性CAG或PCI,比较延迟RIPC(手术前24小时单侧上臂5分钟充气4个周期)和假性RIPC。主要终点是AKI的发生率,根据肾脏疾病改善全球结局标准定义。次要终点包括住院期间肾脏替代治疗、肾损伤尿液生物标志物的变化、非致死性心肌梗死、卒中、再住院和第90天全因死亡率的发生。共有501例患者(年龄74[66,78]岁)被随机分配到延迟(n = 250)或假(n = 251) RIPC组,其中467例(93.2%)在第90天完成了结局评估。假手术组CA-AKI发生率为7.6%,延迟RIPC组为3.2%(优势比0.4,95%可信区间0.17-0.94;P = .03)。该试验没有足够的动力来显示对次要结局的影响。结论:在接受CAG或PCI的高危患者中,延迟RIPC患者的CA-AKI发生率低于假RIPC患者。这些结果应该在更大规模的试验中得到证实,以调查延迟RIPC的CA-AKI减少是否会带来重要的临床益处。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
European Heart Journal
European Heart Journal 医学-心血管系统
CiteScore
39.30
自引率
6.90%
发文量
3942
审稿时长
1 months
期刊介绍: The European Heart Journal is a renowned international journal that focuses on cardiovascular medicine. It is published weekly and is the official journal of the European Society of Cardiology. This peer-reviewed journal is committed to publishing high-quality clinical and scientific material pertaining to all aspects of cardiovascular medicine. It covers a diverse range of topics including research findings, technical evaluations, and reviews. Moreover, the journal serves as a platform for the exchange of information and discussions on various aspects of cardiovascular medicine, including educational matters. In addition to original papers on cardiovascular medicine and surgery, the European Heart Journal also presents reviews, clinical perspectives, ESC Guidelines, and editorial articles that highlight recent advancements in cardiology. Additionally, the journal actively encourages readers to share their thoughts and opinions through correspondence.
期刊最新文献
DMPK 3' untranslated repeat expansions in unexplained sudden cardiac death in the young. Beyond baseline health Status: additional factors in M-TEER response. Glucagon-like peptide-1 receptor agonists reduce experimental atherosclerosis progression, inflammatory biomarkers and cardiovascular events, irrespective of hyperglycaemia and obesity. Weekly Journal Scan: Navigating the troubled OCEAN of post-ablation antithrombotic management. Anomalous origin of right vertebral artery.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1